Over a third of the U.S. Senate led by Sen. Pat Roberts, Chairman of the U.S. Senate Committee on Agriculture, Nutrition and Forestry, expressed their concern over delays in China's approval process for agri-biotech products in a letter addressed to President Donald Trump.

Despite previous agreements, China has failed to make the necessary revisions to their regulatory system that would provide a stable trade environment for U.S. producers, technology providers, and exporters.

 

In light of ongoing trade negotiations with China, the senators also urged President Trump to capitalize on his forthcoming meeting with President Xi to resolve crucial trade issues and reach an agreement for a "timely, transparent, and science-based system for the approvals of agriculture biotechnology products." 

 

Read the full letter from the U.S. Senate Committee on Agriculture, Nutrition, and Forestry.